DEEPAK NITRITE LTD.-$

Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite Limited, has issued and allotted 80,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) worth ₹100 each, aggregating to ₹80 Crores, to Deepak Phenolics Limited (DPL), another wholly-owned subsidiary. This infusion of funds aims to strengthen DCTL's capital base and support project expenses and general corporate purposes. DCTL operates plants for Fluorination, Nitric Acid, Nitration, and Hydrogenation. The transaction is considered a Related Party Transaction and is conducted on an 'arms length' basis. No governmental or regulatory approvals are required.

Deepak Nitrite Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will remain shut from October 1, 2026, until 48 hours after the declaration of the un-audited standalone and consolidated financial results for the quarter and half-year ending September 30, 2026. This measure is standard practice to prevent insider trading during periods of sensitive financial information disclosure.

Deepak Nitrite Limited announced that its wholly-owned subsidiaries, Deepak Chem Tech Limited (DCTL) and Deepak Phenotics Limited (DPL), have invested a total of ₹175 Crores in DCTL. DPL invested ₹95 Crores and the Company invested ₹80 Crores through the issuance and allotment of 9% Optionally Convertible Redeemable Preference Shares (OCRPS). The funds are intended to strengthen DCTL's capital base, support project expenses, and general corporate purposes. DCTL operates plants for Fluorination, Nitric Acid, Nitration, and Hydrogenation, with a turnover of ₹172.23 Crores in FY 2025-26. The transactions were conducted on an arm's length basis.

Deepak Nitrite Ltd announced that its wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL), has passed a Settlement Order with the Settlement Officer, Chief Inspector cum Facilitator for Factories, Ahmedabad. The order, dated August 25, 2026, pertains to a violation of Rule 102 of the Gujarat Factories Rules, 1963, under the Occupational Safety, Health and Working Condition Code, 2020. DCTL has settled the matter by paying a penalty of ₹3,00,000. The company stated that this settlement will have no material financial impact beyond the penalty amount.

Deepak Nitrite Ltd announced the resignation of Mr. Puneet Sharma, SBU Head - Life Sciences. His resignation is effective from the close of business hours on August 21, 2026. Mr. Sharma cited an opportunity outside the organization as the reason for his departure. He has been with the company for a significant period and played a role in shaping the Life Sciences division. The company expects a seamless transition, and Mr. Sharma will work closely with management to onboard his successor.

Deepak Nitrite Limited has officially updated its Board of Directors' composition effective August 7, 2026. This follows the earlier intimations regarding the cessation of Shri Diteep Choksi as an Independent Director and other board changes announced on April 3, 2026, and May 15, 2026. The company has provided a detailed list of its current board members, including Chairman & Managing Director, Deputy Managing Directors, Directors, and Independent Directors, confirming the effective date of these changes.

Shri Diteep Choksi, an Independent Director at Deepak Nitrite Ltd, has completed his second term and consequently ceased to be an Independent Director effective August 7, 2026. This disclosure is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided the necessary details as required by SEBI regulations, confirming the cessation due to the completion of the director's tenure. No further details regarding appointment or relationships were applicable as this is a cessation event.

Deepak Chem Tech Limited, a wholly-owned subsidiary of Deepak Nitrite Ltd, has commissioned its manufacturing operations for Methyl Isobutyl Ketone & Methyl Isobutyl Carbinol at Dahej, Gujarat. The plant, along with its offsite utilities and infrastructure, commenced operations on August 6th, 2026. The total capital expenditure incurred for this project is approximately ₹735 Crores as of the commencement date. This expansion is expected to bolster the company's production capabilities in key chemical intermediates.

Deepak Nitrite Ltd has uploaded the audio recording of its Q1 & FY 2027 Earnings Conference Call. The recording is available on the company's website at the provided weblink. This action is in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, allowing stakeholders to access the discussion regarding the company's financial performance and outlook.

Deepak Nitrite Limited held its 55th Annual General Meeting (AGM) on Wednesday, August 5, 2026, via Video Conferencing/Other Audio Visual Means. The meeting commenced at 11:30 AM IST and concluded at 1:15 PM IST. The AGM was conducted in compliance with MCA and SEBI circulars, as well as applicable provisions of the Companies Act, 2013. Key agenda items included the adoption of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, and the declaration of a dividend. The meeting was attended by the Chairman & Managing Director, other Directors, Key Managerial Personnel, and statutory and secretarial auditors. A total of 70 members attended the AGM.